Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Psychosom Med. 2011 Sep 23;73(8):638–642. doi: 10.1097/PSY.0b013e3182306a4f

Table 1.

Descriptive statistics for BDNF concentration, depression measures, and covariates in the total sample and separately for women and men

Total (N1 = 2099) Women (N = 1297) Men (N = 802)
BDNF concentrations
Serum BDNF, ng/ml 14 (3.0) 14.2 (3.0) 13.8 (3.1)
Plasma BDNF, pg/ml 247.4 (191.6) 258.2 (194.8) 226.5 (183.9)
Depression measures
CES-D 12.3 (7.9) 13.7 (8.5) 10.0 (6.1)
 CES-D ≥ 20 324 (15.9%) 267 (21.1%) 57 (7.4%)
 CES-D ≥ 28 114 (5.6%) 101 (8%) 13 (1.7%)
Neuroticism 56.0 (9.5) 58.1 (9.7) 52.5 (8.0)
 Anxiety 56.7 (9.2) 58.6 (9.3) 53.4 (8.1)
 Angry Hostility 53.2 (9.3) 53.5 (9.6) 52.7 (8.8)
 Depression 53.4 (9.6) 54.9 (10.1) 51.0 (8.0)
 Self-Consciousness 51.8 (10.0) 53.1 (10.3) 49.7 (9.1)
 Impulsiveness 46.9 (9.2) 47.1 (9.2) 46.6 (9.2)
 Vulnerability 56.1 (10.7) 58.2 (10.9) 52.6 (9.3)
Covariates
Age 51.4 (15.3) 50.8 (15.2) 52.5 (15.4)
BMI 26.1 (4.6) 25.4 (5.0) 27.4 (3.8)
 BMI ≥ 30 382 (18.2%) 207 (16%) 175 (21.8%)
Current smoker 15% 12% 20%
Ever smoker 38% 25% 61%
SSRI use 2% 2% 1%
1

N = 482 for plasma; N = 2037 for CES-D and for NEO-PI-R. The reported data are means with SD in parenthesis, or counts with percentages if followed by the % sign.

Abbreviations: BDNF, Brain-derived neurotrophic factor; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CES-D, Center for Epidemiological Studies Depression Scale; SSRI = Selective Serotonin Reuptake Inhibitor.